703 related articles for article (PubMed ID: 23095779)
1. American Society of Clinical Oncology 2012 Annual Meeting: highlights from the gynecologic oncology track.
Tewari KS
Int J Gynecol Cancer; 2012 Nov; 22(9):1634-9. PubMed ID: 23095779
[TBL] [Abstract][Full Text] [Related]
2. 2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus Conference.
Stuart GC; Kitchener H; Bacon M; duBois A; Friedlander M; Ledermann J; Marth C; Thigpen T; Trimble E; ;
Int J Gynecol Cancer; 2011 May; 21(4):750-5. PubMed ID: 21543936
[TBL] [Abstract][Full Text] [Related]
3. The global impact of the Gynecologic Cancer InterGroup in enhancing clinical trials in ovarian cancer.
Bacon M; Kitchener H; Stuart GC; Vermorken JB;
Int J Gynecol Cancer; 2011 May; 21(4):746-9. PubMed ID: 21543935
[TBL] [Abstract][Full Text] [Related]
4. Perspectives from American Society of Clinical Oncology: translational and clinical research highlights in breast and colorectal cancers.
Fontanella C; Aprile G; Scartozzi M; Lederer B; Cascinu S; von Minckwitz G
Future Oncol; 2014 Oct; 10(12):1901-6. PubMed ID: 25386808
[TBL] [Abstract][Full Text] [Related]
5. Paradigm shifts in gynecologic oncology.
Casarin J; Bogani G; Multinu F; Mariani A; Abu-Rustum NR; Ghezzi F; Ramirez PT
Int J Gynecol Cancer; 2021 Dec; 31(12):1617. PubMed ID: 34716176
[No Abstract] [Full Text] [Related]
6. Updates in locally advanced pancreatic cancer. Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
Chang BW; Siccion E; Saif MW
JOP; 2010 Jul; 11(4):313-6. PubMed ID: 20601800
[TBL] [Abstract][Full Text] [Related]
7. Strategies and goals: the future of the International Gynecologic Cancer Society: IGCS Presidential Address.
Berek JS
Int J Gynecol Cancer; 2010 Dec; 20(9):1434-9. PubMed ID: 21119361
[No Abstract] [Full Text] [Related]
8. The American Society of Clinical Oncology 2017 Annual Meeting: A review and summary of selected abstracts.
Rimel BJ; Gibson SJ; Sumner DA; Monk BJ
Gynecol Oncol; 2017 Sep; 146(3):443-448. PubMed ID: 28693948
[No Abstract] [Full Text] [Related]
9. Advancing women's cancer care: highlights from the Annual Meeting on Women's Cancer 2007. Report on the 38th Annual Meeting of the Society of Gynecologic Oncologists, San Diego, Calif., March 3-7, 2007.
Petignat P; Gotlieb W
Gynakol Geburtshilfliche Rundsch; 2007; 47(4):240-2. PubMed ID: 17914271
[No Abstract] [Full Text] [Related]
10. American Society of Clinical Oncology--41st annual meeting. Drug highlights II.
Shah S; Yager N
IDrugs; 2005 Jul; 8(7):534-6. PubMed ID: 15973556
[No Abstract] [Full Text] [Related]
11. The American Society of Clinical Oncology 2021 annual (virtual) meeting: A review and summary of selected abstracts.
Salani R; Liu JF
Gynecol Oncol; 2021 Aug; 162(2):245-248. PubMed ID: 34210516
[No Abstract] [Full Text] [Related]
12. American Society of Clinical Oncology 2011 Annual Meeting update: summary of selected gynecologic cancer abstracts.
Tewari KS; Monk BJ
Gynecol Oncol; 2011 Aug; 122(2):209-12. PubMed ID: 21763890
[No Abstract] [Full Text] [Related]
13. American society of clinical oncology--41st annual meeting.
Shah S; Yager N
IDrugs; 2005 Jul; 8(7):525-7. PubMed ID: 15973553
[No Abstract] [Full Text] [Related]
14. Pharmacogenetics and other molecular targets in the management of pancreatic adenocarcinoma. Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
Merika E; Syrigos KN; Saif MW
JOP; 2010 Jul; 11(4):328-30. PubMed ID: 20601804
[TBL] [Abstract][Full Text] [Related]
15. American Society of Clinical Oncology 2013: summary of scientific advancements in gynecologic cancer.
Eskander RN; Tewari KS
Int J Gynecol Cancer; 2014 Jan; 24(1):13-8. PubMed ID: 24300468
[TBL] [Abstract][Full Text] [Related]
16. Consistency of phase III clinical trial abstracts presented at an annual meeting of the American Society of Clinical Oncology compared with their subsequent full-text publications.
Tam VC; Hotte SJ
J Clin Oncol; 2008 May; 26(13):2205-11. PubMed ID: 18445846
[TBL] [Abstract][Full Text] [Related]
17. American society of clinical oncology--41st annual meeting. Immunology.
Shah S; Yager N
IDrugs; 2005 Jul; 8(7):528-30. PubMed ID: 15973554
[No Abstract] [Full Text] [Related]
18. Clinical outcome of pancreatic cancer patients with diabetes mellitus: is diabetes a poor prognostic factor? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
Kang SP; Saif MW
JOP; 2010 Jul; 11(4):334-5. PubMed ID: 20601806
[TBL] [Abstract][Full Text] [Related]
19. Diabetes and pancreatic cancer. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
Hsu C; Saif MW
JOP; 2011 Jul; 12(4):330-3. PubMed ID: 21737889
[TBL] [Abstract][Full Text] [Related]
20. Novel agents for the treatment of pancreatic adenocarcinoma: any light at the end of the tunnel? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
Dimou AT; Syrigos KN; Saif MW
JOP; 2010 Jul; 11(4):324-7. PubMed ID: 20601803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
